The Impact of Suboptimal 25‐Hydroxyvitamin D Levels and Cholecalciferol Replacement on the Pharmacokinetics of Oral Midazolam in Control Subjects and Patients With Chronic Kidney Disease is a research paper published in The Journal of Clinical Pharmacology (2022). On theSindex it has a DataRank of 0.124. It has been cited 1 time, with 1 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0.0198
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 1 citer.
National Institutes of Health
Grant: R01 GM107122
NCATS NIH HHS
Grant: UL1 TR001857
NCATS NIH HHS
Grant: UL1 TR002535
MeSH Terms
Keywords